181 filings
ARS
2023 FY
IRON
Disc Medicine Inc
1 May 24
Annual report to shareholders
5:00pm
DEF 14A
IRON
Disc Medicine Inc
Definitive proxy
1 May 24
5:00pm
DEFA14A
IRON
Disc Medicine Inc
1 May 24
Additional proxy soliciting materials
5:00pm
8-K
IRON
Disc Medicine Inc
2 Apr 24
Regulation FD Disclosure
5:25pm
S-8
IRON
Disc Medicine Inc
21 Mar 24
Registration of securities for employees
8:54am
8-K
sacho7
21 Mar 24
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
8:00am
8-K
ec7rssp0nblmoml47se2
26 Feb 24
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
8:43am
8-K
9mpkttoi71f4mgbd7pgl
7 Feb 24
Departure of Directors or Certain Officers
8:10am
8-K
c03cl3nt crg1op
11 Dec 23
Regulation FD Disclosure
8:35pm
8-K
mpzafd z4
11 Dec 23
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of
12:11pm
EFFECT
qzbkj1z it
7 Dec 23
Notice of effectiveness
12:15am
8-K
3fcs92fs9o p67pmho
5 Dec 23
Entry into a Material Definitive Agreement
4:56pm
POS AM
12b4 e2zk
5 Dec 23
Prospectus update (post-effective amendment)
4:53pm
424B5
081dw27v64m2c
5 Dec 23
Prospectus supplement for primary offering
4:51pm
EFFECT
eus0ur7f
30 Nov 23
Notice of effectiveness
12:15am
UPLOAD
dai5mjmwb4
27 Nov 23
Letter from SEC
12:00am
CORRESP
rs167ey1f5bvs8e
27 Nov 23
Correspondence with SEC
12:00am